TSO3 Inc. (TSE:TOS) – Investment analysts at Desjardins dropped their FY2017 earnings estimates for TSO3 in a report released on Tuesday, according to Zacks Investment Research. Desjardins analyst M. Jarvi now forecasts that the company will post earnings of ($0.03) per share for the year, down from their prior forecast of ($0.01).
COPYRIGHT VIOLATION NOTICE: This piece of content was first published by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark laws. The legal version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/04/21/fy2017-eps-estimates-for-tso3-inc-decreased-by-desjardins-tos-updated-updated.html.
TSO3 (TSE:TOS) traded up 2.03% during mid-day trading on Friday, reaching $3.02. 173,215 shares of the company’s stock were exchanged. The firm’s 50-day moving average is $3.06 and its 200 day moving average is $2.96. The stock’s market capitalization is $277.77 million. TSO3 has a 1-year low of $2.05 and a 1-year high of $3.82.
TSO3 Company Profile
TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for TSO3 Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSO3 Inc. and related companies with MarketBeat.com's FREE daily email newsletter.